TOP DOWN MS/MS FOR POST TRANSLATIONAL MODIFICATION ANALYSIS OF TYPE IV PILI
TOP DOWN MS/MS FOR POST TRANSLATIONAL MODIFICATION ANALYSIS OF TYPE IV PILI
批准号:
8365579
负责人:
JULIA CHAMOT-ROOKE
金额:
$0.46万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-06-01 至 2012-08-09
关键词:
BacteriaBindingBiologyCell AdhesionCellsClinicalCollaborationsCoupledCysteineDisaccharidesDissociationElectronsEnzymesEpithelialEuropeanFundingGram-Negative BacteriaGrantHexosesHospitalsMass Spectrum AnalysisMedicineMinorModificationMonosaccharidesNational Center for Research ResourcesNeisseria meningitidisOrganellesParis, FrancePathogenesisPilumPlayPolymersPost Translational Modification AnalysisPost-Translational Protein ProcessingPrincipal InvestigatorPropertyProteinsResearchResearch InfrastructureResourcesRoleScienceSerineSiteSourceStagingSurveysTechniquesTimeUnited States National Institutes of HealthVirulencecostflexibilityinstrumentpathogenrapid techniqueresearch studytechnique development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources
provided by a Center grant funded by NIH/NCRR. Primary support for the subproject
and the subproject's principal investigator may have been provided by other sources,
including other NIH sources. The Total Cost listed for the subproject likely
represents the estimated amount of Center infrastructure utilized by the subproject,
not direct funding provided by the NCRR grant to the subproject or subproject staff.
For the gram negative bacterium Neisseria Meningitidis, host cell adhesion, bacterial aggregation and colony dissemination are key pathogenic stages moderated by type IV pili. These long, filamentous bacterial organelles are principally composed of the 17-kDa protein PilE, which is arranged in a helical fashion to create a strong and flexible polymer aggregate. PilE is known to carry several post-translational modifications (PTMs), e.g., a methylated N-terminus, cysteine bridge, glycerophos- phorylated serine and the disaccharide diacetamidotrideoxyhexose (DATDH). The DCMR lab, in collaboration with the group of Guillaume Dum¿nil, George Pompidou European Hospital, Paris, has recently demonstrated, using original top-down approaches by mass spectrometry, that half clinical isolates are alternatively modified with a previously uncharacterised monosaccharide, glyceramidotrideoxy- hexose (GATDH) [1]. During the course of this study, the presence of a minor form of pilE bearing two phosphoglycerol moieties led the DCMR lab to further investigate this modification. It appears that the expression of the enzyme that controls this modification is augmented upon contact of the bacterium with host cells. The most recent results localize the sites of the resultant additional phosphoglycerols and show unambiguously that these additional modifications disrupt pilus-pilus binding and thus decrease the aggregative properties of the bacteria. Complementary experiments show that these modifications are necessary for crossing of the epithelial layer, the first stage of pathogenesis. Taken together these results show for the first time that a PTM of type IV pili plays a crucial role in pathogenic virulence of Neisseria Meningitidis, a conclusion that obviously offers exciting prospects for similar pathogens bearing such pili [2]. During this project "top down" analysis of PilE was undertaken using ECD (Electron Capture Dissociation) on a 7-Tesla FT-ICR with promising results. The primary objective of the collaboration with BUSM Resource is to fully explore the potential of FT-ICR MS on a 12-T instrument, coupled with alternative activation techniques such as ETD, CID and IRMPD, and to evaluate ETD performed on an Orbitrap for "top down" PilE PTM characterisation. Development of these techniques to form a rapid method for PTM localization would enable a comprehensive of survey of PTM's across a wider number of Neisseria Meningitidis strains and ultimately other species bearing type IV pilli.
[1] J. Chamot-Rooke, B. Rousseau, F. Lanternier, G. Mikaty, E. Mairey, C. Malosse, G. Bouchoux, V. Pelicic, L. Camoin, X. Nassif, G. Dumenil, , Proc. Nat. Acad. Sci. USA 104, 14783-14788 (2007)
[2] J. Chamot-Rooke, G. Mikaty, C. Malosse, M. Soyer, A. Dumont, J. Gault, P. Martin, M. Trellet, G. Clary, P. Chaffey, L. Camoin, M. Nilges, X. Nassif, G. Dum¿nil, Science, (2011)
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: